.
.
Ključne reči:
.
Sažetak
.
Reference
[1] Kurian SJ, Unnikrishnan MK, Miraj SS, et al. Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects[J]. Arch Med Res, 2021, 52:582-594.
[2] Santacroce L, Inchingolo F, Topi S, et al. Potential beneficial role of probiotics on the outcome of COVID-19 patients: An evolving perspective[J]. Diabetes Metab Syndr, 2021, 15:295-301.
[3] Debnath N, Kumar A, Yadav AK. Probiotics as a biotherapeutics for the management and prevention of respiratory tract diseases[J]. Microbiol Immunol, 2022, 66:277-291.
[4] Inchingolo AD, Cazzolla AP, Di Cosola M, et al. The integumentary system and its microbiota between health and disease[J]. J Biol Regul Homeost Agents, 2021, 35:303-321.
[5] Millares L, Monso E. The Microbiome in COPD: Emerging Potential for Microbiome-Targeted Interventions[J]. Int J Chron Obstruct Pulmon Dis, 2022, 17:1835-1845.
[6] Rastogi S, Singh A, Nandi A, et al. Can the Therapeutic Spectrum of Probiotics be Extended: Exploring Potential of Gut Microbiome[J]. Recent Adv Antiinfect Drug Discov, 2023, 18:120-147.
[7] Johnstone J, Meade M, Lauzier F, et al. Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial[J]. Jama, 2021, 326:1024-1033.
[8] Hasslöf P, Granqvist L, Stecksén-Blicks C, et al. Prevention of Recurrent Childhood Caries with Probiotic Supplements: A Randomized Controlled Trial with a 12-Month Follow-Up[J]. Probiotics Antimicrob Proteins, 2022, 14:384-390.
[9] Bayoumy AB, Mulder CJJ, Mol JJ, et al. Gut fermentation syndrome: A systematic review of case reports[J]. United European Gastroenterol J, 2021, 9:332-342.
[10] Ji T, Zhu X, Shang F, et al. Preventive Effect of Probiotics on Ventilator-Associated Pneumonia: A Meta-analysis of 2428 Patients[J]. Ann Pharmacother, 2021, 55:949-962.
[11] Linares-García L, Cárdenas-Barragán ME, Hernández-Ceballos W, et al. Bacterial and Fungal Gut Dysbiosis and Clostridium difficile in COVID-19: A Review[J]. J Clin Gastroenterol, 2022, 56:285-298.
[12] Lau VI, Xie F, Fowler RA, et al. Health economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): a cost-effectiveness analysis[J]. Can J Anaesth, 2022, 69:1515-1526.
[13] Shenoy S. Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection[J]. Inflamm Res, 2022, 71:13-26.
[14] Wang B, Xie J, Teng Y. A meta-analysis of the effects of probiotics on various parameters in critically ill ventilated individuals[J]. Adv Clin Exp Med, 2023, 32:633-642.
[15] Chen Y, Qi A, Teng D, et al. Probiotics and synbiotics for preventing postoperative infectious complications in colorectal cancer patients: a systematic review and meta-analysis[J]. Tech Coloproctol, 2022, 26:425-436.
[16] Sencio V, Machado MG, Trottein F. The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes[J]. Mucosal Immunol, 2021, 14:296-304.
[17] Heidari Z, Tajbakhsh A, Gheibihayat SM, et al. Probiotics/Prebiotics in Viral Respiratory Infections: Implication for Emerging Pathogens[J]. Recent Pat Biotechnol, 2021, 15:112-136.
[18] Mirzaei R, Attar A, Papizadeh S, et al. The emerging role of probiotics as a mitigation strategy against coronavirus disease, 2019 (COVID-19)[J]. Arch Virol, 2021, 166:1819-1840.
[19] Sharif S, Greer A, Skorupski C, et al. Probiotics in Critical Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials[J]. Crit Care Med, 2022, 50:1175-1186.
[20] Vázquez-Frias R, Consuelo-Sánchez A, Acosta-Rodríguez-Bueno CP, et al. Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study[J]. Paediatr Drugs, 2023, 25:115-126.
[21] Rozga M, Cheng FW, Handu D. Effects of Probiotics in Conditions or Infections Similar to COVID-19 on Health Outcomes: An Evidence Analysis Center Scoping Review[J]. J Acad Nutr Diet, 2021, 121:1841-1854.
[22] Wang Y, Li N, Li Q, et al. Xuanbai Chengqi Decoction Ameliorates Pulmonary Inflammation via Reshaping Gut Microbiota and Rectifying Th17/Treg Imbalance in a Murine Model of Chronic Obstructive Pulmonary Disease[J]. Int J Chron Obstruct Pulmon Dis, 2021, 16:3317-3335.
[23] Şenöztop E, Dokuzlu T, Güngörmüşler M. A comprehensive review on the development of probiotic supplemented confectioneries[J]. Z Naturforsch C J Biosci, 2022, 77:71-84.
[24] Manna S, Chowdhury T, Chakraborty R, et al. Probiotics-Derived Peptides and Their Immunomodulatory Molecules Can Play a Preventive Role Against Viral Diseases Including COVID-19[J]. Probiotics Antimicrob Proteins, 2021, 13:611-623.
[25] El-Sayed EM, Ibrahim KS. Ameliorating effects of probiotics on alterations in iron homeostasis and inflammation in COVID-19[J]. Mol Biol Rep, 2022, 49:5153-5163
[2] Santacroce L, Inchingolo F, Topi S, et al. Potential beneficial role of probiotics on the outcome of COVID-19 patients: An evolving perspective[J]. Diabetes Metab Syndr, 2021, 15:295-301.
[3] Debnath N, Kumar A, Yadav AK. Probiotics as a biotherapeutics for the management and prevention of respiratory tract diseases[J]. Microbiol Immunol, 2022, 66:277-291.
[4] Inchingolo AD, Cazzolla AP, Di Cosola M, et al. The integumentary system and its microbiota between health and disease[J]. J Biol Regul Homeost Agents, 2021, 35:303-321.
[5] Millares L, Monso E. The Microbiome in COPD: Emerging Potential for Microbiome-Targeted Interventions[J]. Int J Chron Obstruct Pulmon Dis, 2022, 17:1835-1845.
[6] Rastogi S, Singh A, Nandi A, et al. Can the Therapeutic Spectrum of Probiotics be Extended: Exploring Potential of Gut Microbiome[J]. Recent Adv Antiinfect Drug Discov, 2023, 18:120-147.
[7] Johnstone J, Meade M, Lauzier F, et al. Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial[J]. Jama, 2021, 326:1024-1033.
[8] Hasslöf P, Granqvist L, Stecksén-Blicks C, et al. Prevention of Recurrent Childhood Caries with Probiotic Supplements: A Randomized Controlled Trial with a 12-Month Follow-Up[J]. Probiotics Antimicrob Proteins, 2022, 14:384-390.
[9] Bayoumy AB, Mulder CJJ, Mol JJ, et al. Gut fermentation syndrome: A systematic review of case reports[J]. United European Gastroenterol J, 2021, 9:332-342.
[10] Ji T, Zhu X, Shang F, et al. Preventive Effect of Probiotics on Ventilator-Associated Pneumonia: A Meta-analysis of 2428 Patients[J]. Ann Pharmacother, 2021, 55:949-962.
[11] Linares-García L, Cárdenas-Barragán ME, Hernández-Ceballos W, et al. Bacterial and Fungal Gut Dysbiosis and Clostridium difficile in COVID-19: A Review[J]. J Clin Gastroenterol, 2022, 56:285-298.
[12] Lau VI, Xie F, Fowler RA, et al. Health economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): a cost-effectiveness analysis[J]. Can J Anaesth, 2022, 69:1515-1526.
[13] Shenoy S. Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection[J]. Inflamm Res, 2022, 71:13-26.
[14] Wang B, Xie J, Teng Y. A meta-analysis of the effects of probiotics on various parameters in critically ill ventilated individuals[J]. Adv Clin Exp Med, 2023, 32:633-642.
[15] Chen Y, Qi A, Teng D, et al. Probiotics and synbiotics for preventing postoperative infectious complications in colorectal cancer patients: a systematic review and meta-analysis[J]. Tech Coloproctol, 2022, 26:425-436.
[16] Sencio V, Machado MG, Trottein F. The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes[J]. Mucosal Immunol, 2021, 14:296-304.
[17] Heidari Z, Tajbakhsh A, Gheibihayat SM, et al. Probiotics/Prebiotics in Viral Respiratory Infections: Implication for Emerging Pathogens[J]. Recent Pat Biotechnol, 2021, 15:112-136.
[18] Mirzaei R, Attar A, Papizadeh S, et al. The emerging role of probiotics as a mitigation strategy against coronavirus disease, 2019 (COVID-19)[J]. Arch Virol, 2021, 166:1819-1840.
[19] Sharif S, Greer A, Skorupski C, et al. Probiotics in Critical Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials[J]. Crit Care Med, 2022, 50:1175-1186.
[20] Vázquez-Frias R, Consuelo-Sánchez A, Acosta-Rodríguez-Bueno CP, et al. Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study[J]. Paediatr Drugs, 2023, 25:115-126.
[21] Rozga M, Cheng FW, Handu D. Effects of Probiotics in Conditions or Infections Similar to COVID-19 on Health Outcomes: An Evidence Analysis Center Scoping Review[J]. J Acad Nutr Diet, 2021, 121:1841-1854.
[22] Wang Y, Li N, Li Q, et al. Xuanbai Chengqi Decoction Ameliorates Pulmonary Inflammation via Reshaping Gut Microbiota and Rectifying Th17/Treg Imbalance in a Murine Model of Chronic Obstructive Pulmonary Disease[J]. Int J Chron Obstruct Pulmon Dis, 2021, 16:3317-3335.
[23] Şenöztop E, Dokuzlu T, Güngörmüşler M. A comprehensive review on the development of probiotic supplemented confectioneries[J]. Z Naturforsch C J Biosci, 2022, 77:71-84.
[24] Manna S, Chowdhury T, Chakraborty R, et al. Probiotics-Derived Peptides and Their Immunomodulatory Molecules Can Play a Preventive Role Against Viral Diseases Including COVID-19[J]. Probiotics Antimicrob Proteins, 2021, 13:611-623.
[25] El-Sayed EM, Ibrahim KS. Ameliorating effects of probiotics on alterations in iron homeostasis and inflammation in COVID-19[J]. Mol Biol Rep, 2022, 49:5153-5163
Objavljeno
2025/03/26
Broj časopisa
Rubrika
Original paper
Sva prava zadržana (c) 2025 Peng Lu
Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.